{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T15:21:47Z","timestamp":1786980107722,"version":"build-2736575974"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2020,8,10]],"date-time":"2020-08-10T00:00:00Z","timestamp":1597017600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,8,10]],"date-time":"2020-08-10T00:00:00Z","timestamp":1597017600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Gynecol Obstet"],"published-print":{"date-parts":[[2020,11]]},"DOI":"10.1007\/s00404-020-05705-0","type":"journal-article","created":{"date-parts":[[2020,8,10]],"date-time":"2020-08-10T10:06:49Z","timestamp":1597054009000},"page":"1081-1086","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Vulvar Hailey\u2013Hailey disease treated with low-dose naltrexone: case report and literature review"],"prefix":"10.1007","volume":"302","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7858-8225","authenticated-orcid":false,"given":"Marina","family":"Sousa Gomes","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joana","family":"Ara\u00fajo Pereira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vera","family":"Trocado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jo\u00e3o Pedro","family":"Prata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vera","family":"Teixeira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paula","family":"Pinheiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,8,10]]},"reference":[{"key":"5705_CR1","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1001\/archderm.1939.01480220064005","volume":"39","author":"H Hailey","year":"1939","unstructured":"Hailey H (1939) Familial benign chronic pemphigus. Arch Dermatol Syphilol 39:679\u2013685","journal-title":"Arch Dermatol Syphilol"},{"issue":"10","key":"5705_CR2","doi-asserted-by":"publisher","first-page":"1344","DOI":"10.1001\/archderm.1993.01680310116027","volume":"129","author":"JS Wieselthier","year":"1993","unstructured":"Wieselthier JS, Pincus SH (1993) Hailey-Hailey disease of the Vulva. Arch Dermatol 129(10):1344. https:\/\/doi.org\/10.1001\/archderm.1993.01680310116027","journal-title":"Arch Dermatol"},{"issue":"5","key":"5705_CR3","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1111\/j.1365-2133.2004.05904.x","volume":"150","author":"J Dhitavat","year":"2004","unstructured":"Dhitavat J, Fairclough RJ, Hovnanian A, Burge SM (2004) Calcium pumps and keratinocytes: lessons from Darier\u2019s disease and Hailey-Hailey disease. Br J Dermatol 150(5):821\u2013828. https:\/\/doi.org\/10.1111\/j.1365-2133.2004.05904.x","journal-title":"Br J Dermatol"},{"issue":"3","key":"5705_CR4","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1111\/j.1365-2133.1992.tb00658.x","volume":"126","author":"SM Burge","year":"1992","unstructured":"Burge SM (1992) Hailey-Hailey disease: the clinical features, response to treatment and prognosis. Br J Dermatol 126(3):275\u2013282. https:\/\/doi.org\/10.1111\/j.1365-2133.1992.tb00658.x","journal-title":"Br J Dermatol"},{"issue":"3","key":"5705_CR5","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1016\/j.jaad.2016.08.039","volume":"76","author":"B Farahnik","year":"2017","unstructured":"Farahnik B, Blattner CM, Mortazie MB, Perry BM, Lear W, Elston DM (2017) Interventional treatments for Hailey-Hailey disease. J Am Acad Dermatol 76(3):551\u2013558.e3. https:\/\/doi.org\/10.1016\/j.jaad.2016.08.039","journal-title":"J Am Acad Dermatol"},{"issue":"3","key":"5705_CR6","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1001\/jamadermatol.2017.5463","volume":"154","author":"S Cao","year":"2018","unstructured":"Cao S, Lilly E, Chen ST (2018) Variable Response to naltrexone in patients with Hailey-Hailey disease. JAMA Dermatol 154(3):362. https:\/\/doi.org\/10.1001\/jamadermatol.2017.5463","journal-title":"JAMA Dermatol"},{"issue":"9","key":"5705_CR7","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1016\/j.jdcr.2019.06.022","volume":"5","author":"A Alajmi","year":"2019","unstructured":"Alajmi A, Jfri A, Lovett A (2019) Hailey-Hailey disease treated successfully with naltrexone and magnesium. JAAD Case Rep 5(9):760\u2013762. https:\/\/doi.org\/10.1016\/j.jdcr.2019.06.022","journal-title":"JAAD Case Rep"},{"issue":"10","key":"5705_CR8","doi-asserted-by":"publisher","first-page":"1018","DOI":"10.1001\/jamadermatol.2017.2446","volume":"153","author":"LN Albers","year":"2017","unstructured":"Albers LN, Arbiser JL, Feldman RJ (2017) Treatment of Hailey-Hailey disease with low-dose naltrexone. JAMA Dermatol 153(10):1018. https:\/\/doi.org\/10.1001\/jamadermatol.2017.2446","journal-title":"JAMA Dermatol"},{"issue":"5","key":"5705_CR9","doi-asserted-by":"publisher","first-page":"1196","DOI":"10.1111\/bjd.16045","volume":"178","author":"V Campbell","year":"2018","unstructured":"Campbell V, McGrath C, Corry A (2018) Low-dose naltrexone: a novel treatment for Hailey-Hailey disease. Br J Dermatol 178(5):1196\u20131198. https:\/\/doi.org\/10.1111\/bjd.16045","journal-title":"Br J Dermatol"},{"issue":"10","key":"5705_CR10","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1001\/jamadermatol.2017.2445","volume":"153","author":"O Ibrahim","year":"2017","unstructured":"Ibrahim O, Hogan SR, Vij A, Fernandez AP (2017) Low-dose naltrexone treatment of familial benign pemphigus (Hailey-Hailey Disease). JAMA Dermatol 153(10):1015. https:\/\/doi.org\/10.1001\/jamadermatol.2017.2445","journal-title":"JAMA Dermatol"},{"issue":"6","key":"5705_CR11","doi-asserted-by":"publisher","first-page":"1500","DOI":"10.1111\/bjd.18861","volume":"182","author":"M Jasans-Barcel\u00f3","year":"2020","unstructured":"Jasans-Barcel\u00f3 M, Curman P, Hagstr\u00f6mer L, Wikstrom JD, Sairafi D (2020) Improvement of Hailey-Hailey disease with low-dose naltrexone. Br J Dermatol 182(6):1500\u20131502. https:\/\/doi.org\/10.1111\/bjd.18861","journal-title":"Br J Dermatol"},{"issue":"7","key":"5705_CR12","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1016\/j.jdcr.2018.07.002","volume":"4","author":"N Kollman","year":"2018","unstructured":"Kollman N, Bass J (2018) Generalized familial benign chronic pemphigus (Hailey-Hailey disease) treated successfully with low-dose naltrexone. JAAD Case Rep 4(7):725\u2013727. https:\/\/doi.org\/10.1016\/j.jdcr.2018.07.002","journal-title":"JAAD Case Rep"},{"issue":"6","key":"5705_CR13","doi-asserted-by":"publisher","first-page":"AB150","DOI":"10.1016\/j.jaad.2017.04.584","volume":"76","author":"Y Li","year":"2017","unstructured":"Li Y, Ibrahim O, Vij A, Billings S, Fernandez A (2017) Hailey-Hailey disease successfully controlled with low-dose naltrexone. J Am Acad Dermatol 76(6):AB150. https:\/\/doi.org\/10.1016\/j.jaad.2017.04.584","journal-title":"J Am Acad Dermatol"},{"issue":"2","key":"5705_CR14","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1016\/j.jaad.2019.04.024","volume":"81","author":"RMC Loughlin","year":"2019","unstructured":"Loughlin RMC, Riera-Monroig J, Morgado-Carrasco D, Giavedoni P, Podlipnik S, Iranzo P, Mascar\u00f3 J (2019) Low-dose\nnaltrexone therapy in benign chronic pemphigus (Hailey-Hailey disease): a case series. J Am Acad Dermatol 81(2):644\u2013646. https:\/\/doi.org\/10.1016\/j.jaad.2019.04.024","journal-title":"J Am Acad Dermatol"},{"issue":"2","key":"5705_CR15","first-page":"56","volume":"19","author":"B Bihari","year":"2013","unstructured":"Bihari B (2013) Low-dose naltrexone for normalizing immune system function. Altern Ther Health Med 19(2):56\u201365","journal-title":"Altern Ther Health Med"},{"issue":"1","key":"5705_CR16","doi-asserted-by":"publisher","first-page":"17","DOI":"10.2174\/138161206775193208","volume":"12","author":"DJ Wallace","year":"2006","unstructured":"Wallace DJ (2006) Is there a role for cytokine based therapies in fibromyalgia. Curr Pharm Des 12(1):17\u201322. https:\/\/doi.org\/10.2174\/138161206775193208","journal-title":"Curr Pharm Des"},{"issue":"4","key":"5705_CR17","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1111\/j.1526-4637.2009.00613.x","volume":"10","author":"J Younger","year":"2009","unstructured":"Younger J, Mackey S (2009) Fibromyalgia symptoms are reduced by low-dose naltrexone: a pilot study. Pain Med 10(4):663\u2013672. https:\/\/doi.org\/10.1111\/j.1526-4637.2009.00613.x","journal-title":"Pain Med"},{"issue":"2","key":"5705_CR18","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1002\/art.37734","volume":"65","author":"J Younger","year":"2013","unstructured":"Younger J, Noor N, McCue R, Mackey S (2013) Low-dose naltrexone for the treatment of fibromyalgia: Findings of a small, randomized, double-blind, placebo-controlled, counterbalanced, crossover trial assessing daily pain levels. Arthritis Rheum 65(2):529\u2013538. https:\/\/doi.org\/10.1002\/art.37734","journal-title":"Arthritis Rheum"},{"issue":"4","key":"5705_CR19","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1007\/s10067-014-2517-2","volume":"33","author":"J Younger","year":"2014","unstructured":"Younger J, Parkitny L, McLain D (2014) The use of low-dose naltrexone (LDN) as a novel anti-inflammatory treatment for chronic pain. Clin Rheumatol 33(4):451\u2013459. https:\/\/doi.org\/10.1007\/s10067-014-2517-2","journal-title":"Clin Rheumatol"},{"issue":"2","key":"5705_CR20","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1124\/jpet.106.118810","volume":"321","author":"D Wang","year":"2007","unstructured":"Wang D, Sun X, Sadee W (2007) Different effects of opioid antagonists on mu-, delta-, and kappa-opioid receptors with and without agonist pretreatment. J Pharmacol Exp Therapeut 321(2):544\u2013552. https:\/\/doi.org\/10.1124\/jpet.106.118810","journal-title":"J Pharmacol Exp Therapeut"},{"issue":"1","key":"5705_CR21","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1089\/apc.1995.9.3","volume":"9","author":"B Bihari","year":"1995","unstructured":"Bihari B (1995) Efficacy of low dose naltrexone as an immune stabilizing agent for the treatment of HIV\/AIDS. AIDS Patient Care 9(1):3. https:\/\/doi.org\/10.1089\/apc.1995.9.3","journal-title":"AIDS Patient Care"},{"key":"5705_CR22","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1016\/J.INTIMP.2016.08.015","volume":"39","author":"Z Yi","year":"2016","unstructured":"Yi Z, Guo S, Hu X, Wang X, Zhang X, Griffin N, Shan F (2016) Functional modulation on macrophage by low dose naltrexone (LDN). Int Immunopharmacol 39:397\u2013402. https:\/\/doi.org\/10.1016\/J.INTIMP.2016.08.015","journal-title":"Int Immunopharmacol"},{"issue":"3","key":"5705_CR23","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1016\/j.mehy.2008.06.048","volume":"72","author":"N Brown","year":"2009","unstructured":"Brown N, Panksepp J (2009) Low-dose naltrexone for disease prevention and quality of life. Med Hypotheses 72(3):333\u2013337. https:\/\/doi.org\/10.1016\/j.mehy.2008.06.048","journal-title":"Med Hypotheses"},{"issue":"2","key":"5705_CR24","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1111\/bph.12687","volume":"172","author":"PL Bigliardi","year":"2015","unstructured":"Bigliardi PL, Neumann C, Teo YL, Pant A, Bigliardi-Qi M (2015) Activation of the \u03b4-opioid receptor promotes cutaneous wound healing by affecting keratinocyte intercellular adhesion and migration. Br J Pharmacol 172(2):501\u2013514. https:\/\/doi.org\/10.1111\/bph.12687","journal-title":"Br J Pharmacol"},{"issue":"2","key":"5705_CR25","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1001\/jamadermatol.2018.4093","volume":"155","author":"C Ekelem","year":"2018","unstructured":"Ekelem C, Juhasz M, Khera P, Mesinkovska NA (2018) Utility of naltrexone treatment for chronic inflammatory dermatologic conditions. JAMA Dermatol 155(2):229\u2013236. https:\/\/doi.org\/10.1001\/jamadermatol.2018.4093","journal-title":"JAMA Dermatol"},{"issue":"8","key":"5705_CR26","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1111\/exd.13021","volume":"25","author":"PL Bigliardi","year":"2016","unstructured":"Bigliardi PL, Dancik Y, Neumann C, Bigliardi-Qi M (2016) Opioids and skin homeostasis, regeneration and ageing. What\u2019s the evidence? Exp Dermatol 25(8):586\u2013591. https:\/\/doi.org\/10.1111\/exd.13021","journal-title":"Exp Dermatol"},{"issue":"2","key":"5705_CR27","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1046\/J.1523-1747.2002.01847.X","volume":"119","author":"PI Song","year":"2002","unstructured":"Song PI, Neparidze N, Armstrong CA, Ansel JC, Park Y-M, Abraham T, Harten B, Zivony A (2002) Human keratinocytes express functional CD14 and toll-like receptor 4. J Investig Dermatol 119(2):424\u2013432. https:\/\/doi.org\/10.1046\/J.1523-1747.2002.01847.X","journal-title":"J Investig Dermatol"},{"issue":"1","key":"5705_CR28","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/S0733-8635(05)70239-4","volume":"19","author":"H Tennyson","year":"2001","unstructured":"Tennyson H, Levine N (2001) Neurotropic and psychotropic drugs in dermatology. Dermatol Clin 19(1):179\u2013197. https:\/\/doi.org\/10.1016\/S0733-8635(05)70239-4","journal-title":"Dermatol Clin"},{"issue":"1","key":"5705_CR29","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1007\/s40257-019-00477-z","volume":"21","author":"IB Lagha","year":"2020","unstructured":"Lagha IB, Ashack K, Khachemoune A (2020) Hailey-Hailey disease: an update review with a focus on treatment data. Am J Clin Dermatol 21(1):49\u201368. https:\/\/doi.org\/10.1007\/s40257-019-00477-z","journal-title":"Am J Clin Dermatol"}],"container-title":["Archives of Gynecology and Obstetrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00404-020-05705-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00404-020-05705-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00404-020-05705-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,9]],"date-time":"2021-08-09T19:50:50Z","timestamp":1628538650000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00404-020-05705-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,10]]},"references-count":29,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2020,11]]}},"alternative-id":["5705"],"URL":"https:\/\/doi.org\/10.1007\/s00404-020-05705-0","relation":{},"ISSN":["0932-0067","1432-0711"],"issn-type":[{"value":"0932-0067","type":"print"},{"value":"1432-0711","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,8,10]]},"assertion":[{"value":"19 January 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 July 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 August 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors have no conflicting interests do declare.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Available.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}]}}